AdventHealth Advanced Heart Failure CME 2025

• Target Audience: cardiologists, internists, advanced practice providers, and multidisciplinary heart failure teams
• Sample video: contact me for sample video
• Information:

Learning Objectives

Identify appropriate timing and indications for referral for heart transplantation and durable mechanical circulatory support.

Evaluate treatment strategies for cardiogenic shock, including the application of echocardiography and hemodynamic monitoring.

Explain the role of cardiogenomics in the management of patients with dilated cardiomyopathy.

Analyze the management of cardiogenic shock and acute myocardial infarction, with a focus on novel percutaneous devices and outcomes in elderly LVAD patients.

Discuss updated treatment options for patients with amyloidosis and hypertrophic cardiomyopathy.

Describe current approaches to expanding access to heart transplantation, including the use of ECMO, donation after circulatory death (DCD), and hepatitis C–positive donors.

Discuss the role of percutaneous valve interventions in patients with underlying heart failure.

The AdventHealth Advanced Heart Failure CME 2025 program is best for cardiologists, internists, advanced practice providers, and multidisciplinary heart failure teams who want evidence‑based updates on the diagnosis and management of advanced heart failure. It emphasizes modern therapeutics, device‑based interventions, and collaborative care strategies to improve patient outcomes.

Who Should Attend

Cardiologists (general & advanced HF specialists) managing patients with complex heart failure.

Internists & hospitalists encountering advanced HF in inpatient and outpatient settings.

Advanced practice providers (NPs, PAs) working in cardiology or internal medicine.

Residents & fellows in cardiology or internal medicine seeking advanced exposure.

Multidisciplinary HF teams (nurses, pharmacists, rehab specialists) supporting patient care.

What You’ll Learn

Advanced therapeutics: updates on guideline‑directed medical therapy (GDMT) and novel pharmacologic agents.

Device‑based interventions: LVADs, ICDs, CRT, and emerging mechanical circulatory support.

Transplantation updates: patient selection, timing, and outcomes in heart transplantation.

Multidisciplinary management: team‑based strategies for inpatient and outpatient HF care.

Case‑based learning: real examples of advanced HF diagnosis and treatment.

Future directions: innovations in digital health, remote monitoring, and precision medicine.

• Topics:

01 When to Refer the Patient with Advanced Heart Failure for Consideration For HF & LVAD

02 Use of Cardiogenomics in Patients with Dilated Cardiomyopathy

03 Use of Echocardiography and Hemodynamics and Patients with Cardiogenic Shock

04 Cardiogenic Shock and Acute Myocardial Infarction

05 Outcomes in Elderly LVAD Patients

06 Frailty Assessment in the Evaluation for Advanced Heart Failure Surgical Therapies (LVAD and Transplant)

07 Updated Treatment Options for Patients with Amyloid & Hypertrophic Cardiomyopathy

08 Novel Percutaneous Devices in the Management of Cardiogenic Shock

09 Strategies to Increase Access to Heart Transplantation- Use of ECMO, Donation After Cardiac Death, and Hepatitis C Positive Donors